These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1001833)

  • 21. Efficacy of spheroplastic and cell-wall competent vaccines for Mycobacterium avium subsp. paratuberculosis in experimentally-challenged baby goats.
    Hines ME; Stiver S; Giri D; Whittington L; Watson C; Johnson J; Musgrove J; Pence M; Hurley D; Baldwin C; Gardner IA; Aly S
    Vet Microbiol; 2007 Mar; 120(3-4):261-83. PubMed ID: 17123751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Preparation and testing of different antibrucellic vaccines].
    Durand M; Lingelser J; Loquerie R; Prunet P
    Dev Biol Stand; 1976; 31():362-76. PubMed ID: 1261748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Trials of immunostimulation of an antitoxic response with levamisole in the immunization of sheep with a combined clostridial vaccine].
    Bineva I; Peĭchev B; Marinov MI
    Vet Med Nauki; 1986; 23(4):35-8. PubMed ID: 2874649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of immune response stimulated in sheep, rabbits and guinea pigs by the administration of multi-component clostridial vaccines.
    Webster AC; Frank CL
    Aust Vet J; 1985 Apr; 62(4):112-4. PubMed ID: 3896219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Results of potency tests of a vaccine against Cl. botulinum type C by different methods.
    Pranter W
    Dev Biol Stand; 1976; 32():185-91. PubMed ID: 793914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and standardization of polyvalent Clostridium perfringens vaccine in Iran.
    Ardehali M; Darakhshan H
    Dev Biol Stand; 1976; 32():31-4. PubMed ID: 187509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mixed vaccine against bacterial anthrax and symptomatic anthrax].
    Blancou JM
    Rev Elev Med Vet Pays Trop; 1974; 27(2):183-7. PubMed ID: 4219888
    [No Abstract]   [Full Text] [Related]  

  • 29. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response of merino sheep to inactivated Corynebacterium pseudotuberculosis vaccine.
    Cameron CM; Minnaar JL; Engelbrecht MM; Purdom MR
    Onderstepoort J Vet Res; 1972 Mar; 39(1):11-24. PubMed ID: 4680096
    [No Abstract]   [Full Text] [Related]  

  • 31. Guinea pig protection test as indicator of potency of oil emulsion foot-and-mouth disease vaccines.
    Black L; Pullen L; Boge A
    Res Vet Sci; 1985 Sep; 39(2):207-11. PubMed ID: 2999930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
    Nair SP; Sen AK
    Acta Virol; 1992 Oct; 36(5):473-8. PubMed ID: 1364024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of storage on the prevalent alum-precipitated hemorrhagic septicaemia vaccine in Pakistan and preparation of a more efficient oil adjuvant vaccine using dense culture of Pasteurella multocida Roberts type 1 on an improved culture medium.
    Sheikh MA; Tasneem K; Zafar MS; Butt IA; Shakoori AR
    Zentralbl Veterinarmed B; 1995 Mar; 42(1):28-34. PubMed ID: 7483898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of alum-absorbed or non-alum-absorbed oil emulsion vaccines containing either pilate or non-pilate Bacteroides nodosus cells in inducing and maintaining resistance of sheep to experimental foot rot.
    Thorley CM; Egerton JR
    Res Vet Sci; 1981 Jan; 30(1):32-7. PubMed ID: 6113626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mouse model to estimate the potency of the diphtheria component in combined vaccines.
    Kreeftenberg JG; van der Gun J; Marsman FR; van Asten JA; Sekhuis VM; Hendriksen CF
    Dev Biol Stand; 1986; 64():21-4. PubMed ID: 2878846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Some observations on the quality control testing of Clostridium chauvoei vaccines.
    Chandler HM
    Dev Biol Stand; 1976; 32():137-41. PubMed ID: 1001827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological differences between strains of Clostridium chauvoei.
    Kerry JB
    Res Vet Sci; 1967 Jan; 8(1):89-97. PubMed ID: 6067707
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of immune response and protection in animals given mink parvovirus vaccines.
    Zhang DL; Yin Z; Wang SZ
    Biologicals; 1997 Mar; 25(1):93-101. PubMed ID: 9167013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemorrhagic septicaemia oil adjuvant vaccine-study of potency test in rabbits-duration of immunity and keeping quality.
    Nangia SS; Baxi KK; Gulrajani TS; Seetharaman C
    Indian Vet J; 1966 Apr; 43(4):279-87. PubMed ID: 5939978
    [No Abstract]   [Full Text] [Related]  

  • 40. Antibody response of guinea-pigs and cattle to a Campylobacter fetus oil emulsion vaccine.
    Cameron CM
    Onderstepoort J Vet Res; 1982 Sep; 49(3):177-9. PubMed ID: 7177598
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.